基本信息
浏览量:93
职业迁徙
个人简介
Dr. Bob Young is a Professor of Chemistry and the Merck Frosst-British Columbia Leadership Chair in Pharmaceutical Genomics, Bioinformatics and Drug Discovery at Simon Fraser University and the Medicinal Chemistry Division Head at the Centre for Drug Research and Development in Vancouver, Canada. Dr. Young’s research focuses on the design and synthesis of small molecule probes to discover and validate biological drug targets, and the design of enzyme inhibitors, and receptor agonists and antagonists for the treatment of osteoporosis, inflammation, atherosclerosis, diabetes and cancer. Dr. Young is a Fellow of the Royal Society of Canada, a Fellow of the Chemistry Institute of Canada, and past President of the Canadian Society for Pharmaceutical Science. Dr. Young received his PhD from the University of British Columbia, and a DIC from Imperial College London. Before joining the faculty at SFU in 2007, Dr. Young was a Vice President at Merck Frosst in Montreal and acting site head of Merck & Co.’s neuroscience research laboratories at Terlings Park.
研究兴趣
论文共 310 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Jimena Perez-Vargas,Liam J. Worrall,Andrea D. Olmstead,Anh-Tien Ton,Jaeyong Lee,Ivan Villanueva,Connor A. H. Thompson, Svenja Dudek,Siobhan Ennis,Jason R. Smith,Tirosh Shapira, Joshua De Guzman,
Medicinal Chemistry Researchno. 7 (2023): 1231-1234
JACS AUno. 11 (2022): 2400-2416
STAR Protocolsno. 2 (2022): 101258-101258
Molecular therapy : the journal of the American Society of Gene Therapyno. 9 (2022): 3034-3051
RSC MEDICINAL CHEMISTRYno. 1 (2021): 43-56
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn